Biomarker development, commercialization, and regulation: individualization of medicine lost in translation

Clin Pharmacol Ther. 2007 Feb;81(2):153-5. doi: 10.1038/sj.clpt.6100088.
No abstract available

Publication types

  • News
  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Biomarkers*
  • Drug Approval
  • Humans
  • Marketing / methods*
  • National Institutes of Health (U.S.)
  • Technology, Pharmaceutical / methods*
  • United States
  • United States Food and Drug Administration

Substances

  • Biomarkers